Eupraxia Pharmaceuticals Inc.
EPRX
$7.51
-$0.07-0.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.30M | 2.47M | 3.07M | 3.27M | 3.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.16M | 6.88M | 8.26M | 7.12M | 7.48M |
| Operating Income | -16.16M | -6.88M | -8.26M | -7.12M | -7.48M |
| Income Before Tax | -16.71M | -6.37M | -8.74M | -6.76M | -7.53M |
| Income Tax Expenses | 11.30K | -600.00 | 5.60K | 2.80K | 1.80K |
| Earnings from Continuing Operations | -16.72M | -6.37M | -8.75M | -6.77M | -7.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.10K | 8.00K | 6.80K | 4.70K | 23.40K |
| Net Income | -16.71M | -6.36M | -8.74M | -6.76M | -7.51M |
| EBIT | -16.16M | -6.88M | -8.26M | -7.12M | -7.48M |
| EBITDA | -16.11M | -6.84M | -8.23M | -7.10M | -7.44M |
| EPS Basic | -0.34 | -0.19 | -0.26 | -0.21 | -0.22 |
| Normalized Basic EPS | -0.20 | -0.11 | -0.15 | -0.12 | -0.13 |
| EPS Diluted | -0.34 | -0.19 | -0.26 | -0.21 | -0.22 |
| Normalized Diluted EPS | -0.20 | -0.11 | -0.15 | -0.12 | -0.13 |
| Average Basic Shares Outstanding | 51.30M | 36.92M | 35.93M | 35.69M | 35.64M |
| Average Diluted Shares Outstanding | 51.30M | 36.92M | 35.93M | 35.69M | 35.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |